Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Howard W. Robin
|
| gptkbp:collaboratedWith |
gptkb:Eli_Lilly_and_Company
gptkb:Bristol_Myers_Squibb |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
immunology
oncology pain management |
| gptkbp:foundedYear |
1990
|
| gptkbp:founder |
Randall Prather
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nektar Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
NKTR-181
NKTR-214 NKTR-358 |
| gptkbp:numberOfEmployees |
~400
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
NKTR
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.nektar.com/
|
| gptkbp:bfsParent |
gptkb:Roy_Whitfield
|
| gptkbp:bfsLayer |
7
|